Blueprint Medicines shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in Blueprint Medicines
Tip: Access up to 7 years of quarterly data
All positions including Blueprint Medicines held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Blueprint Medicines by Bank of New York Mellon
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $27M | 296k | 92.50 |
| 2024-06-30 | $30M | 274k | 107.78 |
| 2024-03-31 | $23M | 241k | 94.86 |
| 2023-12-31 | $24M | 261k | 92.24 |
| 2023-09-30 | $13M | 267k | 50.22 |
| 2023-06-30 | $17M | 263k | 63.20 |
| 2023-03-31 | $12M | 264k | 44.99 |
| 2022-12-31 | $12M | 263k | 43.81 |
| 2022-09-30 | $15M | 260k | 58.82 |
| 2022-06-30 | $12M | 239k | 50.51 |
| 2022-03-31 | $16M | 247k | 63.88 |
| 2021-12-31 | $67M | 643k | 103.45 |
| 2021-09-30 | $71M | 687k | 102.81 |
| 2021-06-30 | $61M | 695k | 87.96 |
| 2021-03-31 | $65M | 671k | 97.23 |
| 2020-12-31 | $56M | 503k | 112.15 |
| 2020-09-30 | $44M | 471k | 92.70 |
| 2020-06-30 | $36M | 453k | 79.55 |
| 2020-03-31 | $20M | 341k | 58.48 |
| 2019-12-31 | $17M | 212k | 80.11 |
| 2019-09-30 | $15M | 208k | 73.47 |
| 2019-06-30 | $20M | 213k | 94.33 |
| 2019-03-31 | $16M | 194k | 80.06 |
| 2018-12-31 | $9.8M | 182k | 53.90 |
| 2018-09-30 | $15M | 192k | 78.06 |
| 2018-06-30 | $12M | 192k | 63.47 |
| 2018-03-31 | $19M | 205k | 91.71 |
| 2017-12-31 | $15M | 194k | 75.41 |
| 2017-06-30 | $8.9M | 175k | 50.67 |
| 2017-03-31 | $4.8M | 121k | 39.99 |
| 2016-12-31 | $2.6M | 94k | 28.06 |
| 2016-09-30 | $2.6M | 86k | 29.72 |
| 2016-06-30 | $1.4M | 71k | 20.24 |